ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,353, issued on Oct. 7, was assigned to STALICLA SA (Geneva).
"Biomarker assay for use in monitoring autism" was invented by Lynn Durham (Geneva).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to protein kinase A (PKA) for use in diagnosing autism spectrum disorder (ASD) phenotype 1 in an ASD patient wherein PKA levels are measured in a sample of the patient and wherein ASD phenotype 1 is diagnosed if the measured levels are lower than PKA levels in an age and sex-matched control sample. Additionally, the present invention relates to PKA for use in monitoring variation in ASD severity in an ASD patient, wherein PKA levels ...